# A Trial of Low-dose Adjunctive alTeplase During prIMary PCI

Study · id `cardio:ct-nct02257294` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02257294](<https://clinicaltrials.gov/study/NCT02257294>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02257294

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 440 participants.

## Technical summary

Registry record NCT02257294. Randomized; triple masking; primary purpose treatment. Start 2016-03 (actual); primary completion 2018-07 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 440 participants (enrolled count; ClinicalTrials.gov record NCT02257294, source copy `cardio:ctgov-nct02257294-2019-09-06`, retrieved 2026-10-26)
- Started: 2016-03 (actual) (ClinicalTrials.gov record NCT02257294, source copy `cardio:ctgov-nct02257294-2019-09-06`, retrieved 2026-10-26)
- Primary completion: 2018-07 (actual) (ClinicalTrials.gov record NCT02257294, source copy `cardio:ctgov-nct02257294-2019-09-06`, retrieved 2026-10-26)
- Completion: 2019-05-08 (actual) (ClinicalTrials.gov record NCT02257294, source copy `cardio:ctgov-nct02257294-2019-09-06`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT02257294, source copy `cardio:ctgov-nct02257294-2019-09-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02257294-2019-09-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Trial of Low-dose Adjunctive alTeplase During prIMary PCI
- Acronym: T-TIME
- Condition: Myocardial Infarction
- Intervention (Drug): Alteplase
- Intervention (Other): Placebo
- Lead sponsor: NHS Greater Glasgow and Clyde
- Lead sponsor class: OTHER
- Collaborator: University of Glasgow
- Collaborator class: OTHER
- Collaborator: National Institute for Health Research, United Kingdom
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Alteplase (Activase) (`cardio:alteplase`)
- Registry lists this organization as the lead sponsor: NHS Greater Glasgow and Clyde (`cardio:org-nhs-greater-glasgow-and-clyde`)
- Registry lists this organization as a collaborator: University of Glasgow (`cardio:org-university-of-glasgow`)
- Registry lists this organization as a collaborator: National Institute for Health Research, United Kingdom (`cardio:org-national-institute-for-health-research-united-kingdom`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention on Microvascular Obstruction in Patients With Acute Myocardial Infarction: A Randomized Clinical Trial (`cardio:pubmed-30620371`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effects of Intracoronary Alteplase on Microvascular Function in Acute Myocardial Infarction (`cardio:pubmed-31986989`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Low-Dose Alteplase During Primary Percutaneous Coronary Intervention According to Ischemic Time (`cardio:pubmed-32216909`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: ecf8d4583fff74c803aa1be3e0004228a45a98db372cead5d4bc5f0380203eeb
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
